欢迎阅读《欧洲治疗学杂志》2023 年 12 月刊(第 29 卷第 4 期)和最新消息

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL
Ayşe Balat, Ş. Eren, M. Menzilcioğlu, İlhan Bahsi, İlkay Doğan, Davut Sinan Kaplan, M. Karadağ, A. Özçelik, Fatih Sarı, Hamit Yıldız
{"title":"欢迎阅读《欧洲治疗学杂志》2023 年 12 月刊(第 29 卷第 4 期)和最新消息","authors":"Ayşe Balat, Ş. Eren, M. Menzilcioğlu, İlhan Bahsi, İlkay Doğan, Davut Sinan Kaplan, M. Karadağ, A. Özçelik, Fatih Sarı, Hamit Yıldız","doi":"10.58600/eurjther1968","DOIUrl":null,"url":null,"abstract":"Dear Colleagues, In this editorial, we would like to share with you important developments in the European Journal of Therapeutics (Eur J Ther). First of all, as the editorial team, we would like you to know that we hold frequent meetings to benefit our esteemed colleagues and continue to work with great devotion in line with our goal of taking the journal further. We have previously shared with you that we have applied to many indexes. It is with great pleasure that we would like to inform you that in the last few months, more of our index applications have been approved. Index Copernicus, as a result of this application, the ICV 2022 value of our journal was determined to be 100 (approved 2023-10-31) [1] BASE (Bielefeld Academic Search Engine) (approved 2023-11-30) [2] Sherpa Romeo (approved 2023-09-27) [3] MIAR (approved 2023-10-16) [4] All indexes in our journal are currently included on the journal web page [5]. As the editorial team, we would like to inform you that we have determined a policy on this issue for our journal [6], taking into account the recommendations of important international ethics committees such as the Committee on Publication Ethics (COPE) [7] and the World Association of Medical Editors (WAME) [8], which have recently become a trendy topic of discussion about AI chatbots and academic studies prepared with the support of such tools. As you know, when our journal was founded in 1990 [9], it was published in two yearly issues. It is an essential responsibility for us to carry our journal, which continued its publication life with three issues a year in 2009 [10] and four issues a year in 2014 [11]. With your valuable support, we would like to announce that we will increase our journal to 6 issues a year as of 2024 (February, April, June, August, October and December) with the rapidly growing progress of our journal. Unfortunately, we cannot share the names of the referees who made significant contributions to our journal in 2023 due to the changes in the article submission interface during the year and the inaccessibility of some data in the previous interface. However, we would like to emphasize again that we are grateful to all of them for their valuable contributions. Moreover, to expand our journal's referee list, we would like to remind you that competent academics who volunteer in this regard can fill out the “Become a Reviewer for the European Journal of Therapeutics” form [12]. Finally, we would like to point out that we have strengthened our editorial team with an academician competent in dentistry, Fatih Sari, DDS, PhD. Fatih Sari, DDS, PhD, is a new Editorial Board Member of the Eur J Ther. Dr. Sari is an Associate Professor in the Department of Prosthodontics at the Gaziantep University Faculty of Dentistry. He is a Vice Dean of the Faculty of Dentistry and Head of Clinical Departments. Dr. Sari is a prosthodontist and a member of the Turkish Dental Association. He has experience in implant-supported fixed prostheses, Cad/Cam applications and dental materials. We look forward to being able to offer you a large number of high-quality and valuable articles over the coming year. In addition, we would like to thank the readers, authors and reviewers of the Eur J Ther for their continuous support. Sincerely yours,","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"9 5","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Welcome to the December 2023 Issue (Vol:29, No:4) and Current News of the European Journal of Therapeutics\",\"authors\":\"Ayşe Balat, Ş. Eren, M. Menzilcioğlu, İlhan Bahsi, İlkay Doğan, Davut Sinan Kaplan, M. Karadağ, A. Özçelik, Fatih Sarı, Hamit Yıldız\",\"doi\":\"10.58600/eurjther1968\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear Colleagues, In this editorial, we would like to share with you important developments in the European Journal of Therapeutics (Eur J Ther). First of all, as the editorial team, we would like you to know that we hold frequent meetings to benefit our esteemed colleagues and continue to work with great devotion in line with our goal of taking the journal further. We have previously shared with you that we have applied to many indexes. It is with great pleasure that we would like to inform you that in the last few months, more of our index applications have been approved. Index Copernicus, as a result of this application, the ICV 2022 value of our journal was determined to be 100 (approved 2023-10-31) [1] BASE (Bielefeld Academic Search Engine) (approved 2023-11-30) [2] Sherpa Romeo (approved 2023-09-27) [3] MIAR (approved 2023-10-16) [4] All indexes in our journal are currently included on the journal web page [5]. As the editorial team, we would like to inform you that we have determined a policy on this issue for our journal [6], taking into account the recommendations of important international ethics committees such as the Committee on Publication Ethics (COPE) [7] and the World Association of Medical Editors (WAME) [8], which have recently become a trendy topic of discussion about AI chatbots and academic studies prepared with the support of such tools. As you know, when our journal was founded in 1990 [9], it was published in two yearly issues. It is an essential responsibility for us to carry our journal, which continued its publication life with three issues a year in 2009 [10] and four issues a year in 2014 [11]. With your valuable support, we would like to announce that we will increase our journal to 6 issues a year as of 2024 (February, April, June, August, October and December) with the rapidly growing progress of our journal. Unfortunately, we cannot share the names of the referees who made significant contributions to our journal in 2023 due to the changes in the article submission interface during the year and the inaccessibility of some data in the previous interface. However, we would like to emphasize again that we are grateful to all of them for their valuable contributions. Moreover, to expand our journal's referee list, we would like to remind you that competent academics who volunteer in this regard can fill out the “Become a Reviewer for the European Journal of Therapeutics” form [12]. Finally, we would like to point out that we have strengthened our editorial team with an academician competent in dentistry, Fatih Sari, DDS, PhD. Fatih Sari, DDS, PhD, is a new Editorial Board Member of the Eur J Ther. Dr. Sari is an Associate Professor in the Department of Prosthodontics at the Gaziantep University Faculty of Dentistry. He is a Vice Dean of the Faculty of Dentistry and Head of Clinical Departments. Dr. Sari is a prosthodontist and a member of the Turkish Dental Association. He has experience in implant-supported fixed prostheses, Cad/Cam applications and dental materials. We look forward to being able to offer you a large number of high-quality and valuable articles over the coming year. In addition, we would like to thank the readers, authors and reviewers of the Eur J Ther for their continuous support. Sincerely yours,\",\"PeriodicalId\":42642,\"journal\":{\"name\":\"European Journal of Therapeutics\",\"volume\":\"9 5\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2023-12-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.58600/eurjther1968\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58600/eurjther1968","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

亲爱的同事们,在这篇社论中,我们想与您分享《欧洲治疗学杂志》(Eur J Ther)的重要发展。首先,作为编辑团队,我们希望您知道,我们经常召开会议,为我们尊敬的同事谋福利,并将继续以极大的热情投入工作,以实现我们将期刊推向更高水平的目标。我们曾与大家分享过,我们已经申请了许多索引。我们非常高兴地通知大家,在过去的几个月里,我们有更多的索引申请获得了批准。 哥白尼索引》,由于该申请,我们期刊的 ICV 2022 值被确定为 100(2023-10-31 批准)[1] BASE(比勒费尔德学术搜索引擎)(2023-11-30 批准)[2] Sherpa Romeo(2023-09-27 批准)[3] MIAR(2023-10-16 批准)[4] 目前,我们期刊的所有索引都包含在期刊网页[5]中。作为编辑团队,我们想告诉您,我们已经确定了本期刊在此问题上的政策[6],并考虑了重要的国际伦理委员会(如出版伦理委员会(COPE)[7]和世界医学编辑协会(WAME)[8])的建议,最近关于人工智能聊天机器人和在此类工具支持下编写的学术研究的讨论已成为一个时髦的话题。众所周知,我们的期刊于 1990 年创刊[9],每年出版两期。2009 年[10]和 2014 年[11],我们每年出版三期,延续了期刊的出版生命。在您的宝贵支持下,我们谨此宣布,随着我们期刊的快速发展,我们将从 2024 年起把期刊增加到每年 6 期(2 月、4 月、6 月、8 月、10 月和 12 月)。遗憾的是,由于文章提交界面在这一年中发生了变化,且之前界面中的一些数据无法访问,我们无法与大家分享在 2023 年为本刊做出重大贡献的审稿人姓名。不过,我们还是要再次强调,我们非常感谢他们所有人的宝贵贡献。此外,为了扩大我们期刊的审稿人名单,我们想提醒大家,有能力的学者如果自愿参与,可以填写 "成为《欧洲治疗学杂志》审稿人 "表格 [12]。最后,我们要指出的是,我们的编辑团队中增添了一位牙科方面的专家--Fatih Sari,牙科博士。法提赫-萨里(Fatih Sari)牙科博士是《欧洲治疗学杂志》的新编委。萨里博士是加济安泰普大学牙科学院修复学系副教授。他是牙科学院副院长兼临床系主任。萨里博士是一名口腔修复学家,也是土耳其牙科协会会员。他在种植体支持固定修复、Cad/Cam 应用和牙科材料方面拥有丰富的经验。我们期待在未来的一年里能为您提供大量高质量、有价值的文章。此外,我们还要感谢《欧洲牙科杂志》的读者、作者和审稿人一直以来的支持。此致敬礼
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Welcome to the December 2023 Issue (Vol:29, No:4) and Current News of the European Journal of Therapeutics
Dear Colleagues, In this editorial, we would like to share with you important developments in the European Journal of Therapeutics (Eur J Ther). First of all, as the editorial team, we would like you to know that we hold frequent meetings to benefit our esteemed colleagues and continue to work with great devotion in line with our goal of taking the journal further. We have previously shared with you that we have applied to many indexes. It is with great pleasure that we would like to inform you that in the last few months, more of our index applications have been approved. Index Copernicus, as a result of this application, the ICV 2022 value of our journal was determined to be 100 (approved 2023-10-31) [1] BASE (Bielefeld Academic Search Engine) (approved 2023-11-30) [2] Sherpa Romeo (approved 2023-09-27) [3] MIAR (approved 2023-10-16) [4] All indexes in our journal are currently included on the journal web page [5]. As the editorial team, we would like to inform you that we have determined a policy on this issue for our journal [6], taking into account the recommendations of important international ethics committees such as the Committee on Publication Ethics (COPE) [7] and the World Association of Medical Editors (WAME) [8], which have recently become a trendy topic of discussion about AI chatbots and academic studies prepared with the support of such tools. As you know, when our journal was founded in 1990 [9], it was published in two yearly issues. It is an essential responsibility for us to carry our journal, which continued its publication life with three issues a year in 2009 [10] and four issues a year in 2014 [11]. With your valuable support, we would like to announce that we will increase our journal to 6 issues a year as of 2024 (February, April, June, August, October and December) with the rapidly growing progress of our journal. Unfortunately, we cannot share the names of the referees who made significant contributions to our journal in 2023 due to the changes in the article submission interface during the year and the inaccessibility of some data in the previous interface. However, we would like to emphasize again that we are grateful to all of them for their valuable contributions. Moreover, to expand our journal's referee list, we would like to remind you that competent academics who volunteer in this regard can fill out the “Become a Reviewer for the European Journal of Therapeutics” form [12]. Finally, we would like to point out that we have strengthened our editorial team with an academician competent in dentistry, Fatih Sari, DDS, PhD. Fatih Sari, DDS, PhD, is a new Editorial Board Member of the Eur J Ther. Dr. Sari is an Associate Professor in the Department of Prosthodontics at the Gaziantep University Faculty of Dentistry. He is a Vice Dean of the Faculty of Dentistry and Head of Clinical Departments. Dr. Sari is a prosthodontist and a member of the Turkish Dental Association. He has experience in implant-supported fixed prostheses, Cad/Cam applications and dental materials. We look forward to being able to offer you a large number of high-quality and valuable articles over the coming year. In addition, we would like to thank the readers, authors and reviewers of the Eur J Ther for their continuous support. Sincerely yours,
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Journal of Therapeutics
European Journal of Therapeutics MEDICINE, GENERAL & INTERNAL-
自引率
0.00%
发文量
48
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信